The Scan
UK Funds to Stay Ahead of Variants
The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.
Push for Access
In a letter, researchers in India seek easier access to COVID-19 data, Science reports.
Not as Cold
Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.
Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones
In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.
Watching These
According to Reuters, a panel of scientific advisors in India has identified some SARS-CoV-2 variants to watch.
Number of False Positives
The Washington Post looks into a series of false positive test results for SARS-CoV-2 in Maryland.
Markers of Depression
The Economist reports that researchers have identified biomarkers that could help diagnose depression.
PNAS Papers on Breast Cancer Hypoxia, EMT Networks, Oral Cancer Immune Checkpoints
In PNAS this week: role for ADAM12 in hypoxia-related metastasis risk, signaling pathways linked to the epithelial to mesenchymal transition, and more.
Eli Broad Dies
Eli Broad, a philanthropist whose donations enabled the establishment of the Broad Institute, has died, according to the Boston Globe.
Wasted Doses
Kaiser Heath News reports that two pharmacy chains account for most of the wasted SARS-CoV-2 vaccine doses in the US.